Related Experiment Video
Updated: Jul 13, 2026
08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Rho kinase (ROCK) inhibitors
James K Liao1, Minoru Seto, Kensuke Noma
1The Vascular Medicine Research Unit, Brigham and Women's Hospital, Cambridge 02139 and Harvard Medical School, Boston, Massachusetts, USA. jliao@rics.bwh.harvard.edu
Journal of Cardiovascular Pharmacology
|August 2, 2007
Summary
Rho kinase (ROCK) signaling is crucial in cardiovascular disease. ROCK inhibitors are being developed as potential therapeutics for hypertension and atherosclerosis, offering benefits beyond lipid lowering.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
Background:
- Rho kinase (ROCK) isoforms, ROCK1 and ROCK2, are downstream effectors of the Rho GTP-binding protein.
- ROCKs regulate fundamental cellular processes including shape, motility, secretion, proliferation, and gene expression.
- The ROCK pathway is implicated in vascular tone, proliferation, inflammation, and oxidative stress, all relevant to cardiovascular disease.
Purpose of the Study:
- To elucidate the regulation and downstream targets of ROCK isoforms.
- To investigate potential differential functions of ROCK1 and ROCK2.
- To explore the role of ROCK inhibition in cardiovascular disease therapeutics.
Main Methods:
- This study reviews existing literature on ROCK signaling and its cardiovascular implications.
- Analysis of preclinical data on ROCK involvement in hypertension and atherosclerosis.
- Examination of the potential for ROCK inhibitors in cardiovascular disease treatment.
Main Results:
- ROCKs play a significant role in cardiovascular pathophysiology.
- ROCK inhibition may contribute to the pleiotropic effects of statin therapy.
- Animal studies suggest ROCK involvement in hypertension and atherosclerosis.
Conclusions:
- ROCK pathway dysregulation is linked to cardiovascular disease.
- ROCK inhibitors represent a promising therapeutic strategy for cardiovascular conditions.
- Further research is needed to understand ROCK regulation and clinical efficacy.
Related Concept Videos
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: